Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer signs drug profiling deal with Nodality

August 10, 2012
Research and Development, Sales and Marketing Lupus, Nodality, Pfizer, SCNP

Pfizer has signed a multi-year drug profiling deal with Nodality to help get the best from its autoimmune disease compounds. …

News
screen_shot_2012-08-10_at_10

Former Pfizer head Kindler joins Lux Capital

August 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kindler, Pfizer

Venture capital firm Lux Capital has appointed former Pfizer chairman and chief executive Jeff Kindler as a partner. Kindler will …

Appointment

Fuji buys Thai manufacturing facility from DKSH

August 9, 2012
Manufacturing and Production DKSH, Fuji, OLIC, Thai

Japan’s Fuji Pharma has bought Thailand’s largest pharmaceutical contract manufacturing organisation OLIC from current owner DKSH. In a deal that …

News
Amanda Paxon image

Working Life: Amanda Paxon

August 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amanda Paxon, Boehringer Ingelheim, Working Life

 How did you find your way into your current role? Through a combination of good luck and hard work! I …

Feature
Zelboraf image

NICE still minded not to recommend Zelboraf

August 9, 2012
Sales and Marketing BMS, NICE, QALY, Yervoy, Zelboraf

NICE is asking Roche for more information about its melanoma pill Zelboraf, saying it is still too expensive and its …

News

Amgen scraps pancreatic cancer drug

August 9, 2012
Research and Development, Sales and Marketing Amgen, GAMMA, Ganitumab, pancreatic

Biotech company Amgen has abandoned its late-stage trial of a new drug for one of the most hard-to-treat of all …

News
Nicholson image

Nicholson to end NHS black listing of drugs

August 9, 2012
Sales and Marketing IHW, NHS, NICE, Sir David Nicholson, formulary

The chief executive of the NHS is looking to stamp out black listing of NICE-approved medicines. In a letter to …

News

Cambridge University gains stem cell centre funding

August 9, 2012
Research and Development, Sales and Marketing Cambridge, MRC, Wellcome Trust, stem cell

The Wellcome Trust and the Medical Research Council are investing £8 million into a new stem cell research centre. The …

News
David Willetts image

UK government to create four new ‘eHealth’ centres

August 9, 2012
Sales and Marketing MRC, NHS, data, eHealth, investment, patient records

A consortium of ten UK government and charity groups has invested £19 million to create a series of eHealth research …

News
screen_shot_2012-08-09_at_11

NHS Board appointments

August 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NHS, government

Further Commissioning Support Unit (CSU) managing directors have been announced by the NHS Board Authority.

Appointment

UK doctors must prepare for the rise of the ‘ePatient’

August 9, 2012
Medical Communications, Sales and Marketing ABPI, GPs, digital

Doctors and other healthcare professionals must prepare for the rise of ‘ePatients’ in the coming years and keep apace with …

News
screen_shot_2012-08-08_at_16

ABPI appoints UK pharma team to head VBP discussion

August 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, VBP

The ABPI has announced the team which will represent the pharma industry in negotiations with the government to agree the …

Appointment

Pfizer pays $60m in bribery cases

August 8, 2012
Sales and Marketing DoJ, FDA, GSK, Janssen, Pfizer, Wyeth, bribery

Pfizer has been fined $60 million for making improper payments to doctors in Europe, Asia and the Middle East. The …

News
Astrazeneca image

AstraZeneca and BTG sepsis drug fails

August 8, 2012
Research and Development, Sales and Marketing AZD977, AstraZeneca, BTG, CytoFab, sepsis

AstraZeneca’s pipeline has suffered another blow with the troubled company halting development of an investigational sepsis drug following poor Phase …

News
charles-howeson

Appointments made to NHS property services

August 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Charles Howeson, NHS

The company set up by the government to manage all the ex-PCT estate not transferred to providers (NHS Property Services), …

Appointment

GSK’s Votrient gains new licence

August 8, 2012
Sales and Marketing GSK, NICE, Votrient, soft cell sarcoma

GlaxoSmithKline has gained a new European licence for its cancer pill Votrient adding to its renal cell carcinoma licence. The …

News

Regeneron to expand workforce at New York facility

August 8, 2012
Manufacturing and Production Arcalyst, Eylea, Regeneron, Zaltrap

Buoyant product sales at US biotech Regeneron have prompted the company to undertake a recruitment drive at its manufacturing facility …

News
Champix image

Champix better than patches for smoking cessation

August 7, 2012
Sales and Marketing Champix, FDA, Pfizer, Zyban, smoking

New research shows that Pfizer’s Champix is better than nicotine patch therapy at helping smokers kick the habit. A Pfizer …

News

Ticking all the Boxes

August 7, 2012
Manufacturing and Production

Pharmaceutical packaging has many functions to perform but in the OTC area of the market brand owners and product manufactures …

Feature
Thought Leadership
GE Healthcare image

GE and iBio expand plant production alliance

August 7, 2012
Manufacturing and Production GE Healthcare, iBio, iBioLaunch

GE Healthcare and iBio have forged an alliance to commercialise plant-based technologies for the manufacture of biologic drugs and vaccines. …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026